These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24066305)

  • 21. Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion.
    Zhu B; Sun Y; Sievers RE; Browne AE; Pulukurthy S; Sudhir K; Lee RJ; Chou TM; Chatterjee K; Parmley WW
    J Am Coll Cardiol; 2000 Mar; 35(3):787-95. PubMed ID: 10716484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Renin-Angiotensin-Aldosterone System Regulates Sarcoidosis Granulomatous Inflammation.
    Crouser ED; Julian MW; Locke LW; Bicer S; Mitchell JR; Singha A; Kramer PJ; Rajaram MVS; Raman SV
    Am J Respir Crit Care Med; 2024 Aug; 210(4):497-507. PubMed ID: 38941161
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts.
    Kawabata H; Ryomoto T; Ishikawa K
    Hypertens Res; 2001 Jul; 24(4):403-9. PubMed ID: 11510753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-response studies with idrapril in the rat heart during acute myocardial ischaemia and reperfusion.
    Riva E; Traquandi C
    Eur J Pharmacol; 1996 Oct; 312(3):293-300. PubMed ID: 8894611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Captopril and L-arginine have a synergistic cardioprotective effect in ischemic-reperfusion injury in the isolated rat heart.
    Greenberg S; Chernin G; Shapira I; George J; Wollman Y; Laniado S; Keren G
    J Cardiovasc Pharmacol Ther; 2000 Oct; 5(4):281-90. PubMed ID: 11150398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: evidence of an e-NOS mRNA overexpression after global ischemia.
    Barsotti A; Di Napoli P; Taccardi AA; Spina R; Stuppia L; Palka G; Barbacane RC; De Caterina R; Conti P
    Atherosclerosis; 2001 Mar; 155(1):53-9. PubMed ID: 11223426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous angiotensin-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats.
    Al-Maghrebi M; Benter IF; Diz DI
    Pharmacol Res; 2009 Apr; 59(4):263-8. PubMed ID: 19166939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the angiotensin AT1 receptor blocker candesartan on myocardial ischemic/reperfusion injury.
    Shimizu M; Sjöquist PO; Wang QD; Rydén L
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S137-42. PubMed ID: 9892154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats.
    Pechanova O; Matuskova J; Capikova D; Jendekova L; Paulis L; Simko F
    Kidney Int; 2006 Jul; 70(1):170-6. PubMed ID: 16710350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion.
    Brunner F; Kukovetz WR
    Circulation; 1996 Oct; 94(7):1752-61. PubMed ID: 8840871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
    Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
    Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Captopril cardioplegia on myocardial protection in the hypertrophied rat hearts.
    Zhang YH; Xu SC
    Int J Cardiol; 1994 Dec; 47(2):131-7. PubMed ID: 7721480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the angiotensin II subtype 1 receptor antagonist losartan on functional recovery of isolated rat hearts undergoing global myocardial ischemia-reperfusion.
    Flynn JD; Akers WS
    Pharmacotherapy; 2003 Nov; 23(11):1401-10. PubMed ID: 14620386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AT(1) and AT(2) receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts.
    Xu Y; Kumar D; Dyck JR; Ford WR; Clanachan AS; Lopaschuk GD; Jugdutt BI
    Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1206-15. PubMed ID: 11893553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition.
    Al-Shafei AI; Wise RG; Gresham GA; Carpenter TA; Hall LD; Huang CL
    J Physiol; 2002 Jan; 538(Pt 2):555-72. PubMed ID: 11790819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin receptor blockers and aldosterone antagonists in chronic heart failure.
    Miller AB; Srivastava P
    Cardiol Clin; 2001 May; 19(2):195-202, v. PubMed ID: 11407105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: an emerging paradigm in diabetic nephropathy: a systematic review.
    Mavrakanas TA; Gariani K; Martin PY
    Eur J Intern Med; 2014 Feb; 25(2):173-6. PubMed ID: 24315413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposite effects of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts.
    Ford WR; Clanachan AS; Jugdutt BI
    Circulation; 1996 Dec; 94(12):3087-9. PubMed ID: 8989113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effects of addition of mineralocorticoid receptor antagonist to angiotensin II receptor blocker in patients with diabetic nephropathy: a randomized clinical trial.
    Esteghamati A; Noshad S; Jarrah S; Mousavizadeh M; Khoee SH; Nakhjavani M
    Nephrol Dial Transplant; 2013 Nov; 28(11):2823-33. PubMed ID: 24009294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.